Top headlines: RBI monetary policy; test to screen multiple Covid variants

India Inc finances face a threat from the rise in interest rate in recent months. More on that story in our top headlines.

RBI
RBI ( Photo: Bloomberg)
BS Web team New Delhi
2 min read Last Updated : Dec 06 2021 | 8:15 AM IST
Pune-based biotech firm Mylab Discovery Solutions is working on a new technology platform that would not only detect the presence of coronavirus in a sample, but also be able to screen the variant. More on that story in our top headlines this morning.

RBI may wait and watch, say economists; status quo likely on all fronts 

The monetary policy on December 8 will be followed widely by analysts, for it may reveal the Reserve Bank of India’s (RBI’s) perception of a “behind the curve” fear chasing major global central banks, which no longer see inflation being “transitory”, while economic uncertainties are rising amid a new variant of coronavirus. Read more

India Inc faces a risk to profits as bond yields go up 46 basis points 

Rising inflation and higher input costs are not the only risks to corporate earnings in the forthcoming quarters. India Inc finances also face a threat from the rise in interest rate in recent months as indicated by the yield on the 10-year Government of India bond.  Read more

Sharp rise in valuables purchase pushed up India's GDP growth in Q2 

Owing to their ability to hedge against inflation, people bought gold, precious stones and art works at a brisk pace during the second quarter (Q2) of 2021-22. This played a crucial part in jacking up the gross domestic product (GDP) growth.  Read more

Biotech firm Mylab developing test to screen multiple Covid variants 

Pune-based biotech firm Mylab Discovery Solutions is working on a new technology platform that would not only detect the presence of coronavirus in a sample, but also be able to screen the variant.  Read more

Microfinance business may attract closer scrutiny on the way it is done 

Is all well among microfinance institutions (MFIs)? Just about everybody will tell you that collections are back on track. But the latest Micro-lend report by CRIF High Mark notes the portfolio-at-risk (PAR) in the 30 days past the due date bucket worsened to 15.4 per cent in June 2021 from 9.7 per cent in March 2021. Read more


 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Reserve Bank of IndiaCoronavirusRBI

Next Story